Johnson & Johnson to Provide Drug Prices in TV Ads
HealthDay News — In a drug industry first, Johnson & Johnson will start giving the list prices of its prescription drugs in television ads. The new policy will begin in late March with the popular...
View ArticleASA: Reversal Agent Cuts Severe Bleeding With Factor Xa Inhibitors
HealthDay News — The reversal agent, andexanet alfa, effectively reduces life-threatening bleeding in patients treated with factor Xa inhibitors, according to a study published online February 7 in the...
View ArticleASA: Intensive BP Control Lowers Bleeding Risk in Stroke Patients
HealthDay News — Stroke patients who receive intensive blood pressure lowering are less likely to suffer brain bleeds when treated with clot-busting therapies, according to a study published online...
View ArticleGuidelines Updated for Pulmonary Arterial Hypertension in Adults
HealthDay News — In the latest evidence-based guideline from the American College of Chest Physicians, published online January 17 in CHEST, updated recommendations are provided for the management of...
View ArticleArtificially Sweetened Drinks Linked to Stroke After Menopause
HealthDay News — Among postmenopausal women, consumption of artificially sweetened beverages (ASB) is associated with an increased risk for stroke, coronary heart disease, and all-cause mortality,...
View ArticleDischarge Opioid Rx for Heart Disease Patients May Impact Follow-Up
HealthDay News — For patients with an admitting diagnosis of acute coronary syndrome and/or acute decompensated heart failure, opioid prescription at discharge is not significantly associated with...
View ArticleFDA Warns About ‘Miracle’ Young Blood Infusion Treatments
HealthDay News — The use of plasma infusion therapies (often called “vampire” treatments, in which people undergo infusions of a young donor’s blood) is on the rise across the United States, often...
View ArticleEating Nuts Tied to Reduced CVD Incidence, Death in T2DM Patients
HealthDay News — Higher consumption of nuts, especially tree nuts, is associated with reduced cardiovascular disease (CVD) incidence and mortality among patients with type 2 diabetes, according to a...
View ArticleTrial Evaluating Epanova for MACE Risk Reduction Discontinued
AstraZeneca is discontinuing a phase 3 trial evaluating Epanova (omega-3 carboxylic acids) in patients with mixed dyslipidemia who are at high risk of cardiovascular disease (CVD), as findings from...
View ArticleOzempic Approved to Reduce Risk of Major Adverse Cardiovascular Events
The Food and Drug Administration (FDA) has approved a new indication for Ozempic (semaglutide; Novo Nordisk) injection to reduce the risk of major adverse cardiovascular events (MACE) in adults with...
View ArticleMeta-Analyses Link Rosiglitazone to Increased Cardiovascular Risk
HealthDay News – Rosiglitazone seems to be associated with an increased cardiovascular risk, particularly heart failure, according to data from a systematic review and meta-analyses published online...
View ArticleInvestigational Therapy for Hypoxic-Ischemic Encephalopathy Gets Orphan Drug...
The Food and Drug Administration (FDA) has granted Orphan Drug designation to PIC1-dPEG24 (ReAlta Life Sciences) for the treatment of hypoxic-ischemic encephalopathy (HIE) in neonates....
View ArticleFDA Approves Software That Allows HCPs Without Prior Experience to Perform...
The Food and Drug Administration (FDA) has authorized marketing of Caption Guidance software (Caption Health) to assist medical professionals in the acquisition of cardiac ultrasound images. Caption...
View ArticleTrulicity Approved to Reduce Risk of Major Adverse Cardiovascular Events
The Food and Drug Administration (FDA) has approved Trulicity (dulaglutide; Lilly) to reduce the risk of major adverse cardiovascular events (MACE; cardiovascular death, nonfatal myocardial infarction...
View Article5 Surprising Cardiovascular Disease Risk Factors Your Patients May Not Know
While cardiovascular disease may be common and commonly known to patients, they may not know some of the surprising factors in their diet and medical history that may actually be putting them at risk....
View ArticleJohnson & Johnson to Provide Drug Prices in TV Ads
HealthDay News — In a drug industry first, Johnson & Johnson will start giving the list prices of its prescription drugs in television ads. The new policy will begin in late March with the popular...
View ArticleASA: Reversal Agent Cuts Severe Bleeding With Factor Xa Inhibitors
HealthDay News — The reversal agent, andexanet alfa, effectively reduces life-threatening bleeding in patients treated with factor Xa inhibitors, according to a study published online February 7 in the...
View ArticleASA: Intensive BP Control Lowers Bleeding Risk in Stroke Patients
HealthDay News — Stroke patients who receive intensive blood pressure lowering are less likely to suffer brain bleeds when treated with clot-busting therapies, according to a study published online...
View ArticleGuidelines Updated for Pulmonary Arterial Hypertension in Adults
HealthDay News — In the latest evidence-based guideline from the American College of Chest Physicians, published online January 17 in CHEST, updated recommendations are provided for the management of...
View ArticleArtificially Sweetened Drinks Linked to Stroke After Menopause
HealthDay News — Among postmenopausal women, consumption of artificially sweetened beverages (ASB) is associated with an increased risk for stroke, coronary heart disease, and all-cause mortality,...
View Article
More Pages to Explore .....